Viewing Study NCT01303302


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2026-01-15 @ 3:00 AM
Study NCT ID: NCT01303302
Status: COMPLETED
Last Update Posted: 2016-09-22
First Post: 2011-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The TANTALUS® II for the Treatment of Type 2 Diabetes
Sponsor: MetaCure (USA), Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module